| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Androgen receptor expression in prostate cancer stem cells: is there a conundrum?
|
Sharifi, Nima
|
|
2007
|
62 |
5 |
p. 921-923
|
artikel
|
| 2 |
An in vitro and in vivo study of the combination of the heat shock protein inhibitor 17-allylamino-17-demethoxygeldanamycin and carboplatin in human ovarian cancer models
|
Banerji, Udai
|
|
2008
|
62 |
5 |
p. 769-778
|
artikel
|
| 3 |
A phase II study of capecitabine plus gemcitabine in patients with locally advanced or metastatic pancreatic cancer
|
Song, Hong Suk
|
|
2007
|
62 |
5 |
p. 763-768
|
artikel
|
| 4 |
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study
|
Rodon, Jordi
|
|
2008
|
62 |
5 |
p. 911-919
|
artikel
|
| 5 |
Celecoxib inhibits growth of tumors in a syngeneic rat liver metastases model for colorectal cancer
|
Heer, Pieter de
|
|
2008
|
62 |
5 |
p. 811-819
|
artikel
|
| 6 |
7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway
|
Hsu, Tzu-Sheng
|
|
2008
|
62 |
5 |
p. 809
|
artikel
|
| 7 |
7-Chloro-6-piperidin-1-yl-quinoline-5,8-dione (PT-262), a novel synthetic compound induces lung carcinoma cell death associated with inhibiting ERK and CDC2 phosphorylation via a p53-independent pathway
|
Hsu, Tzu-Sheng
|
|
2008
|
62 |
5 |
p. 799-808
|
artikel
|
| 8 |
Clinical pharmacokinetics of bevacizumab in patients with solid tumors
|
Lu, Jian-Feng
|
|
2008
|
62 |
5 |
p. 779-786
|
artikel
|
| 9 |
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment
|
Heijns, Joan B.
|
|
2008
|
62 |
5 |
p. 841-847
|
artikel
|
| 10 |
Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells
|
Ji, Chao
|
|
2008
|
62 |
5 |
p. 857-865
|
artikel
|
| 11 |
Cytotoxic effects of treosulfan and busulfan against leukemic cells of pediatric patients
|
Munkelt, Doreen
|
|
2008
|
62 |
5 |
p. 821-830
|
artikel
|
| 12 |
Inhibition of P-glycoprotein and multidrug resistance protein 1 by dietary phytochemicals
|
Nabekura, Tomohiro
|
|
2008
|
62 |
5 |
p. 867-873
|
artikel
|
| 13 |
In vitro and in vivo evaluation of combined calcitriol and cisplatin in dogs with spontaneously occurring tumors
|
Rassnick, Kenneth M.
|
|
2008
|
62 |
5 |
p. 881-891
|
artikel
|
| 14 |
2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis
|
Kar, Siddhartha
|
|
2008
|
62 |
5 |
p. 831-840
|
artikel
|
| 15 |
2-Methoxyestradiol reverses doxorubicin resistance in human breast tumor xenograft
|
Azab, Samar S.
|
|
2008
|
62 |
5 |
p. 893-902
|
artikel
|
| 16 |
Oxaliplatin-induced immune mediated thrombocytopenia
|
Beg, Muhammad S.
|
|
2008
|
62 |
5 |
p. 925-927
|
artikel
|
| 17 |
Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
|
Ku, Geoffrey Y.
|
|
2008
|
62 |
5 |
p. 875-880
|
artikel
|
| 18 |
Pretreatment with 5-FU enhances cisplatin cytotoxicity in head and neck squamous cell carcinoma cells
|
Ijichi, Kei
|
|
2007
|
62 |
5 |
p. 745-752
|
artikel
|
| 19 |
S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
|
Furuse, Junji
|
|
2008
|
62 |
5 |
p. 849-855
|
artikel
|
| 20 |
Successful treatment of non-islet cell tumor hypoglycemia in hepatocellular carcinoma with doxorubicin
|
Kampitak, Thatchai
|
|
2008
|
62 |
5 |
p. 929-930
|
artikel
|
| 21 |
The role of topoisomerases and RNA transcription in the action of the antitumour benzonaphthyridine derivative SN 28049
|
Bridewell, David J. A.
|
|
2007
|
62 |
5 |
p. 753-762
|
artikel
|
| 22 |
Toxicity and antitumor activity of the vitamin D analogs PRI-1906 and PRI-1907 in combined treatment with cyclophosphamide in a mouse mammary cancer model
|
Wietrzyk, Joanna
|
|
2008
|
62 |
5 |
p. 787-797
|
artikel
|
| 23 |
Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer
|
Bartsch, Rupert
|
|
2008
|
62 |
5 |
p. 903-910
|
artikel
|
Tijdschrift beschrijving